NQO1 and cancer: This naphthoquinone is now under investigation for the treatment of specific cancers associated with elevated NQO1 levels, such as breast, non-small cell lung, pancreatic, colon, and prostate cancers [34,35,36,37], and is currently in phase II clinical trials for the treatment of pancreatic cancer [38].